A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder.
about
Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disordersNMDA receptors and fear extinction: implications for cognitive behavioral therapyPharmacological treatment of PTSD - established and new approachesAggression in young children with concurrent callous-unemotional traits: can the neurosciences inform progress and innovation in treatment approaches?Pharmacological treatment of anxiety disorders: current treatments and future directionsPharmacotherapy for anxiety disorders in children and adolescentsPharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disordersCanadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disordersThe evidence-based pharmacotherapy of social anxiety disorderD-cycloserine effects on extinction of conditioned responses to drug-related cuesDeletion of glutamate delta-1 receptor in mouse leads to aberrant emotional and social behaviorsDose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationaleThe Future of D-Cycloserine and Other Cognitive Modifiers in Obsessive-Compulsive and Related DisordersChronic antidepressant treatment impairs the acquisition of fear extinction.How the neurocircuitry and genetics of fear inhibition may inform our understanding of PTSD.Neurobiological correlates of cognitions in fear and anxiety: a cognitive-neurobiological information-processing model.Fear conditioning, synaptic plasticity and the amygdala: implications for posttraumatic stress disorderPharmacological enhancement of fear reduction: preclinical models.Stress modulation of cognitive and affective processesSeeking a spotless mind: extinction, deconsolidation, and erasure of fear memoryFibroblast growth factor-2 enhances extinction and reduces renewal of conditioned fearGlutamate receptors in extinction and extinction-based therapies for psychiatric illnessD-cycloserine facilitation of fear extinction and exposure-based therapy might rely on lower-level, automatic mechanisms.A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorderTesting the effects of Δ9-THC and D-cycloserine on extinction of conditioned fear in humans.A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans.Does D-cycloserine enhance exposure therapy for anxiety disorders in humans? A meta-analysis.Novel approaches in treatment of pediatric anxiety.Sleep quality predicts treatment outcome in CBT for social anxiety disorder.Combining d-cycloserine with motor training does not result in improved general motor learning in neurologically intact people or in people with stroke.Opposing effects of D-cycloserine on fear despite a common extinction duration: interactions between brain regions and behavior.D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorderA placebo-controlled trial of phenelzine, cognitive behavioral group therapy, and their combination for social anxiety disorderStructural determinants of D-cycloserine efficacy at the NR1/NR2C NMDA receptorsDoes d-Cycloserine Augmentation of CBT Improve Therapeutic Homework Compliance for Pediatric Obsessive-Compulsive Disorder?A novel treatment for tinnitus and tinnitus-related cognitive difficulties using computer-based cognitive training and D-cycloserineNeuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia.Enhancing exposure therapy for anxiety disorders, obsessive-compulsive disorder and post-traumatic stress disorder.Impaired extinction retention in adolescent rats: effects of D-cycloserine.New approaches to combining pharmacotherapy and psychotherapy for posttraumatic stress disorder.
P2860
Q24187995-1634125F-6FFA-4990-AEB5-71E4FD9AF323Q24604822-CD3D2B49-4519-4668-A782-35C1DD44671CQ24633256-4A56A13D-3AB7-4980-8CCE-2E6D6E8AF7BDQ24642833-2B0A6435-3855-4D19-84E3-5F0A213A1B56Q26851461-B2E1CD16-87BB-467A-B67A-1EBEAAB6F5D8Q26853715-CE3DCF23-882A-4149-A5A9-D94FDEDBAA70Q27006437-111DF64A-02AC-4D56-A7E2-0E997A784EA2Q27009995-782B964C-6C8C-4D59-B6A5-B02344421A99Q28262456-5E881A04-225A-4C74-BE8C-C0C90C192ED6Q28266461-B9B7C7C2-8B70-496F-9E27-664C8173F09FQ28512821-CD7F4F5A-ECCA-4034-8364-B120F227721AQ30380118-567E349D-8839-45A7-83C7-994D8D74E8A1Q30426498-5F720E82-8F33-4D1B-8EE1-1E6062C95B41Q30437449-9D4C152D-41A6-43D1-BF4B-5A05F0D1365FQ30456148-17CBED93-00DD-49FC-96E0-9B3A6307D2DCQ30458551-E887FAC1-9F9E-4DCD-A014-B3B4BB1A2115Q30459672-A24D72B9-1F38-47F8-A628-166C0436DD5CQ30462825-2F87FEE4-CE0B-44AC-8036-BFB35E2EF6F7Q30464319-3998306A-B927-4EBB-827F-97433277FEDFQ30466738-BCE0EDE6-A32B-42BA-BB42-6BCEA71CF88CQ30475516-A314701B-B6B9-478D-B214-EA172D47B1D8Q30477927-28A0E66A-1A94-4D40-A4C1-9AF932E4BCEFQ30479274-9311642C-C963-4A85-B8C0-CB44B28E6CCEQ30498105-8570B2B4-D333-461E-B45D-59D62BB761DEQ30525198-A5366469-7361-4E61-9837-8448610FB0E3Q30585383-EE47CC9F-5447-4203-B202-97B9E52C81E9Q31171981-03AF2B4F-61E6-412C-93B2-87B061C1A1E3Q33598320-EF04BFF4-F589-4DA3-BFB2-D54A355FC5D5Q33704893-B049CBF8-2849-4FFD-9B03-52722DB31782Q33708292-9D9F68C1-A412-4426-935A-B26A2207FBDAQ33740875-9CB8C306-49DF-4C64-839F-D68AB876A736Q33760626-94A9DCDF-C8A0-40C6-9C60-DE02CF00487BQ33798078-69B24CC6-0FDB-4B61-A52A-0CBDF000C7D2Q33821292-39287462-0E66-41F6-AE37-5F838D5E2F41Q33835384-4244FBE5-E907-49EA-9DE5-822A93B0813CQ33912531-D4180679-5D65-4B39-A552-D9D12D868C50Q33966168-06B2A2A6-3EC1-4DAB-89FA-F14ED09BD134Q34017493-2132A5E4-C28F-466A-B87B-06F222FA0DF4Q34022949-4A21F821-7F84-4407-B962-5098B656BCEFQ34206188-A2AF9CEA-1238-429D-8BAD-378046AB796A
P2860
A randomized controlled trial of D-cycloserine enhancement of exposure therapy for social anxiety disorder.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
A randomized controlled trial ...... y for social anxiety disorder.
@en
A randomized controlled trial ...... y for social anxiety disorder.
@nl
type
label
A randomized controlled trial ...... y for social anxiety disorder.
@en
A randomized controlled trial ...... y for social anxiety disorder.
@nl
prefLabel
A randomized controlled trial ...... y for social anxiety disorder.
@en
A randomized controlled trial ...... y for social anxiety disorder.
@nl
P50
P1476
A randomized controlled trial ...... y for social anxiety disorder.
@en
P2093
Adam J Guastella
Jonathan E Gaston
P304
P356
10.1016/J.BIOPSYCH.2007.11.011
P407
P577
2008-01-07T00:00:00Z